Funding cuts and patient safety in research are critical issues that have surfaced as significant barriers to advancing medical science and protecting those involved in clinical trials.Recent federal funding reductions, particularly a $2 billion freeze on grants to Harvard University, have raised alarm bells regarding the oversight of patient safety regulations.